Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Induced Constipation × methylnaltrexone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Opioid-Induced Constipation 1 Neoplasms 1 Constipation 1

Interventions

naloxegol 6 tegaserod 3 naldemedine 3 prucalopride 1 methylnaltrexone 1 linaclotide 1 alvimopan 1 Polyethylene Glycols 1 Oxycodone 1 Magnesium Hydroxide 1 Lubiprostone 1 Electrolytes 1 Electroacupuncture 1 Dosage Forms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00858754 2019-11-29

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Bausch Health Americas, Inc.

Phase 4 Withdrawn

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡